An interventional study of Fetal Selective Reduction Technology and Potassium Chloride in Chromosome Abnormality and Twin Pregnancy With Antenatal Problem, sponsored by Shanghai First Maternity and Infant Hospital. Status unknown. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2016-12-05.
Sponsored by Shanghai First Maternity and Infant Hospital · Not applicable, Interventional, and Treatment
The risk of abnormal chromosome and structure is much higher in twins than in singletons, and traditional early pregnancy screening strategy for single pregnancy is not suitable for twins. Based on our management experience of fetal medicine at twin pregnancy, and multi-center cooperation, the study will carry out the following clinical studies:
58 studies on the registry are indexed under Chromosome Aberrations; 13 are open to participants now.
This study's planned enrollment of 1,300 is above the median of 260 across 15 interventional studies indexed under Chromosome Aberrations.
Browse Chromosome Aberrations studies →Shanghai First Maternity and Infant Hospital is the lead sponsor of 48 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Potassium chloride fetal heart injection in the dichorial twins with abnormal chromosome and structure
Procedure: Fetal Selective Reduction Technology · Drug: Potassium Chloride
normal dichorial twins without any intervention
Fetal Selective Reduction Technology will be conducted according to different gestational weeks: before 16weeks, 16\~24 weeks, 24\~27+6 weeks,\>28weeks
Success rate for the operation
Time frame: 1 week
long-term complications after surgery
Time frame: 1 year
No study locations are listed for this record.
Plan to share: Undecided — The Individual Participant Data sharing plan will be discussed with the other collaborators
No publications or documents are linked to this record.
This study is status unknown, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Potassium Chloride
Shanghai First Maternity and Infant Hospital